ApoE polymorphism in dilated cardiomyopathy and advanced heart failure

被引：0
|
作者：
Goncalvesova, E.
Jurkovicova, D.
Sedlakova, B.
Hudecova, S.
Luknar, M.
Krizanova, O.
机构：
[1] Nat Inst Cardiovasc Ctr, Dept Heart Failure Transplantat, Bratislava, Slovakia
[2] Slovak Acad Sci, Inst Mol Physiol & Genet, Bratislava 83334, Slovakia
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2007年 / 6卷
关键词：
D O I：
10.1016/S1567-4215(07)60072-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：27 / 27
页数：1
相关论文
共 50 条
  • [21] Hypocalcemic dilated cardiomyopathy: rare cause of heart failure
    Chraibi, S
    Drighil, A
    Nafidi, S
    Zahraoui, M
    Tahiri, A
    Chraibi, N
    ANNALES DE MEDECINE INTERNE, 2001, 152 (07): : 483 - 485
  • [22] Genetics and genomics of dilated cardiomyopathy and systolic heart failure
    Tayal, Upasana
    Prasad, Sanjay
    Cook, Stuart A.
    GENOME MEDICINE, 2017, 9
  • [23] Electrophysiological effects of levosimendan administration in patients with advanced heart failure secondary to ischemic or dilated cardiomyopathy
    Kanoupakis, E. M.
    Kallergis, E. M.
    Mavrakis, H. E.
    Lyrarakis, G. M.
    Koutalas, E. P.
    Goudis, C.
    Manios, E. G.
    Vardas, P. E.
    EUROPEAN HEART JOURNAL, 2008, 29 : 301 - 301
  • [24] T1 mapping and conditional survival in paediatric dilated cardiomyopathy with advanced heart failure
    Raj, Shashi
    Kothari, Richa
    Kumar, N. Arun
    Sigamani, Alben
    Raj, Vimal
    CARDIOLOGY IN THE YOUNG, 2021, 31 (12) : 1938 - 1942
  • [25] Electrophysiological effects of levosimendan administration in patients with advanced heart failure secondary to ischemic or dilated cardiomyopathy
    Mavrakis, H. E.
    Kanoupakis, E. M.
    Kallergis, E. M.
    Koutalas, E. P.
    Lathourakis, C. E.
    Nyktari, E. G.
    Manios, E. G.
    Vardas, P. E.
    EUROPEAN HEART JOURNAL, 2007, 28 : 44 - 45
  • [26] T1 Mapping and Conditional Survival in Pediatric Dilated Cardiomyopathy with Advanced Heart Failure
    Raj, S.
    Maiya, S.
    Kothari, R.
    Raj, V.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S131 - S131
  • [27] Skin test anergy in advanced heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy
    Vredevoe, DL
    Woo, MA
    Doering, LV
    Brecht, ML
    Hamilton, MA
    Fonarow, GC
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (03): : 323 - 328
  • [28] Fragmented qrs complex in advanced heart failure caused by ischaemic heart disease or dilated cardiomyopathy: basic differences
    Martinez-Dolz, L.
    Morillas Climent, HHerminio
    Plaza, D.
    Sanchez-Lazaro, I.
    Rivera, J. M.
    Rosello-Lleti, E.
    Tarazon-Melguizo, E.
    Salvador, A.
    Almenar, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 185 - 185
  • [29] HEART-FAILURE IN DILATED CARDIOMYOPATHY AND CORONARY HEART-DISEASE
    REGITZ, V
    SHUG, AL
    SCHULER, S
    YANKAH, C
    HETZER, R
    FLECK, E
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1988, 113 (19) : 781 - 786
  • [30] Catecholamine levels in heart failure due to dilated cardiomyopathy and their relationship to the severity of heart failure
    Agarwal, AK
    Venugopalan, P
    Woodhouse, C
    de Bono, D
    EUROPEAN JOURNAL OF HEART FAILURE, 2000, 2 (03) : 261 - 263
12345